Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

MSLP

Muscle Pharm (CE) (MSLP)

Muscle Pharm Corporation (CE)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:MSLP
日付受信時刻ニュースソース見出しコード企業名
2023/03/1106 : 17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2023/01/1120 : 02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/12/2207 : 22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/09/1919 : 00Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/08/2405 : 54Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/08/2306 : 09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/08/1719 : 01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/07/2905 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/07/2905 : 18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/07/1306 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/06/2305 : 06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/06/1719 : 04Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/06/1505 : 11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/06/1005 : 27Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/05/1805 : 16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/05/1706 : 08Edgar (US Regulatory)Quarterly Report (10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/04/2821 : 16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/04/0108 : 19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/04/0105 : 01Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/03/1206 : 56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2022/02/2301 : 22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:MSLPMuscle Pharm Corporation (CE)
2021/12/3006 : 05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2021/11/1720 : 05Edgar (US Regulatory)Quarterly Report (10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
2021/11/1620 : 08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
2021/11/0303 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2021/10/1405 : 53Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2021/10/0119 : 03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2021/08/1705 : 47Edgar (US Regulatory)Quarterly Report (10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
2021/08/1705 : 42Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
2021/07/2708 : 16GlobeNewswire Inc.MusclePharm Closes Potential $7.3 Million Liability with IRSUSOTC:MSLPMuscle Pharm Corporation (CE)
 Showing the most relevant articles for your search:USOTC:MSLP